Aspirin, Tumor Mutations, & Colorectal Cancer Survival | News Brief

Among patients with mutated-PIK3CA colorectal cancer, regular aspirin use after their diagnosis appears to increase survival. The investigators noted, however, that survival was unchanged for those with wild-type PIK3CA colorectal cancer.

Abstract: New England Journal of Medicine, October 25, 2012.

 

 

 

Physician's Weekly for Current Medical News, Events & Issues